Device Trial Radar · NCT05280366
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
Last checked: Nov 20, 2026Latest source record: Nov 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Feb 9, 2022
Primary completion
Jun 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- New World Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 15, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of the Streamline Surgical System versus competitor
Conditions
- Open Angle Glaucoma
Interventions
Streamline Surgical SystemDevice
Completion of the Streamline Surgical System procedure
iStent Inject WDevice
Implantation of competitor device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in mean unmedicated diurnal Intraocular Pressure (IOP)Time frame: 24 months
Locations
20 sites in 3 countries. Site status is shown where the registry gives one.
Vold Vision
Fayetteville, Arkansas
Visionary Research Institute
Newport Beach, California
Wolstan and Goldberg Eye Associates
Torrance, California
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.